SPONSOR
General Hospital of Shenyang Military Region
Total Trials
8
Recruiting
8
Phases
Phase 4
Conditions studied: Hypertriglyceridemia Induced Acute PancreatitisAlzheimer DiseaseStroke, IschemicIschemic StrokeStroke, Acute IschemicRadiation-Induced Intestinal Injury
General Hospital of Shenyang Military Region is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Hypertriglyceridemia Induced Acute Pancreatitis, Alzheimer Disease, Stroke, Ischemic, Ischemic Stroke.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — General Hospital of Shenyang Military Region
How many clinical trials has General Hospital of Shenyang Military Region sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by General Hospital of Shenyang Military Region, of which 8 are actively recruiting participants. These trials cover conditions including Hypertriglyceridemia Induced Acute Pancreatitis, Alzheimer Disease, Stroke, Ischemic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does General Hospital of Shenyang Military Region research focus on?
General Hospital of Shenyang Military Region clinical trials span Hypertriglyceridemia Induced Acute Pancreatitis, Alzheimer Disease, Stroke, Ischemic, Ischemic Stroke, Stroke, Acute Ischemic, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a General Hospital of Shenyang Military Region clinical trial?
To participate in a General Hospital of Shenyang Military Region trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all General Hospital of Shenyang Military Region trials with current recruitment status updated daily.
Clinical Trials by General Hospital of Shenyang Military Region
NCT07388420
Recruiting
Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis
Hypertriglyceridemia Induced Acute Pancreatitis
NCT07294885
Recruiting
Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease
Alzheimer Disease
NCT06170944
Recruiting
Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke
Stroke, Ischemic
NCT06010628 Phase 4
Recruiting
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
Stroke, Ischemic
NCT07172789
Recruiting
Head dOwn Position Before Endovascular Treatment for Large veSsel Occlusion (HOPES5)
Ischemic Stroke
NCT06010641
Recruiting
Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3)
Stroke, Acute Ischemic
NCT07344610
Recruiting
Effects of Short-term Intensive Statin Therapy on Lipid Levels
Ischemic Stroke
NCT06410443
Recruiting
Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury
Radiation-Induced Intestinal Injury
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology